310 related articles for article (PubMed ID: 30311164)
1. Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?
Perez MC; Oliver DE; Weitman ES; Boulware D; Messina JL; Torres-Roca J; Cruse CW; Gonzalez RJ; Sarnaik AA; Sondak VK; Wuthrick EJ; Harrison LB; Zager JS
Ann Surg Oncol; 2019 Feb; 26(2):379-385. PubMed ID: 30311164
[TBL] [Abstract][Full Text] [Related]
2. Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma.
Lee JS; Durham AB; Bichakjian CK; Harms PW; Hayman JA; McLean SA; Harms KL; Burns WR
Ann Surg Oncol; 2019 Feb; 26(2):386-394. PubMed ID: 30556118
[TBL] [Abstract][Full Text] [Related]
3. Completion lymph node dissection for merkel cell carcinoma.
Cramer JD; Suresh K; Sridharan S
Am J Surg; 2020 Oct; 220(4):982-986. PubMed ID: 32087988
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature.
Gupta SG; Wang LC; Peñas PF; Gellenthin M; Lee SJ; Nghiem P
Arch Dermatol; 2006 Jun; 142(6):685-90. PubMed ID: 16785370
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients.
Sims JR; Grotz TE; Pockaj BA; Joseph RW; Foote RL; Otley CC; Weaver AL; Jakub JW; Price DL
Surg Oncol; 2018 Mar; 27(1):11-17. PubMed ID: 29549898
[TBL] [Abstract][Full Text] [Related]
6. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Kraus DH; Brady MS; Coit DG
Ann Surg Oncol; 2011 Sep; 18(9):2529-37. PubMed ID: 21431988
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma: 30-year experience from a single institution.
Santamaria-Barria JA; Boland GM; Yeap BY; Nardi V; Dias-Santagata D; Cusack JC
Ann Surg Oncol; 2013 Apr; 20(4):1365-73. PubMed ID: 23208132
[TBL] [Abstract][Full Text] [Related]
8. Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis.
Stokes JB; Graw KS; Dengel LT; Swenson BR; Bauer TW; Slingluff CL; Ledesma EJ
J Clin Oncol; 2009 Aug; 27(23):3772-7. PubMed ID: 19581538
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in clinically node-negative Merkel cell carcinoma: the Westmead Hospital experience.
Jenkins LN; Howle JR; Veness MJ
ANZ J Surg; 2019 May; 89(5):520-523. PubMed ID: 30959572
[TBL] [Abstract][Full Text] [Related]
10. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma.
Fang LC; Lemos B; Douglas J; Iyer J; Nghiem P
Cancer; 2010 Apr; 116(7):1783-90. PubMed ID: 20162707
[TBL] [Abstract][Full Text] [Related]
11. Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences.
Grotz TE; Joseph RW; Pockaj BA; Foote RL; Otley CC; Bagaria SP; Weaver AL; Jakub JW
Ann Surg Oncol; 2015 Nov; 22(12):4060-6. PubMed ID: 25676844
[TBL] [Abstract][Full Text] [Related]
12. Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.
Ma KL; Sharon CE; Tortorello GN; Perry NJ; Keele LJ; Lukens JN; Karakousis GC; Miura JT
Ann Surg Oncol; 2023 Jul; 30(7):4345-4355. PubMed ID: 37106277
[TBL] [Abstract][Full Text] [Related]
13. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
Servy A; Maubec E; Sugier PE; Grange F; Mansard S; Lesimple T; Marinho E; Couturaud B; Girod A; Albert S; Dendale R; Calitchi E; Sarda L; Chanal J; Deschamps L; Sastre-Garau X; Laroche L; Crickx B; Avril MF
Ann Oncol; 2016 May; 27(5):914-9. PubMed ID: 26811346
[TBL] [Abstract][Full Text] [Related]
15. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
18. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
Uppal A; Stern S; Thompson JF; Foshag L; Mizzollo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Kashani-Sabet M; Coventry BJ; Cochran AJ; Fujita M; Sim-Shin M; Elashoff D; Elashoff RM; Faries MB
Ann Surg Oncol; 2020 Jun; 27(6):1970-1977. PubMed ID: 31863416
[TBL] [Abstract][Full Text] [Related]
19. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
